20
Mylan Laboratories Limited Hyderabad In, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Desmopressin, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2012-176 - Rev 02
This Chemical Type CEP, issued on September 18, 2017, remains in force until July 25, 2018, ensuring its reliability within the pharmaceutical industry.
Substance Number 712 associated with this CEP further emphasizes